OOIR: Observatory of International Research

Papers

(The TQCC of International Clinical Psychopharmacology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	37
The role of personality traits in following quarantine orders during the COVID-19 pandemic	33
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	19
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	18
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	15
Antidepressant psychopharmacology: is inflammation a future target?	14
Clinical specificity profile for novel rapid acting antidepressant drugs	14
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	14
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	14
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	14
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	12
Case series on aripiprazole and dopamine supersensitivity psychosis	11
Open issues in bipolar and antipsychotic treatments	11
Managing depression in the elderly: real-world clinical considerations and perspectives	10
Debated issues in major psychoses	10
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	10
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	10
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	10
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	10
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	10
The Gordian knot of the immune-redox systems’ interactions in psychosis	9
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	9
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	9
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	9
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	9

Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	9
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	9
Innovation in psychopharmacology	8
Elevated liver transaminases among patients with psychiatric disorders	8
Suicide behind bars: time to tackle barriers to mental healthcare access in prisons	8
Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders	8
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	8
Modulating factors in mood disorders treatment	8
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	8
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	7
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	7
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	7
Case report and systematic review of cerebellar vermis alterations in psychosis	7
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis	7
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	6
Allergic reaction induced by subcutaneous administration of ketamine: a case report	6
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	6
Advances in the treatment of depression	6
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	6
Interplay of environmental and clinical factors in psychiatric disorders	6
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	6
Manic episode in a patient with pancreatic adenocarcinoma: a case report	6
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	6
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	6
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	6
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland	6
The challenge of managing difficult to treat psychiatric conditions	5
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	5
Persian translation and validation of community attitudes toward the mentally ill scale: a tool for assessing social stigma about mental illness	5
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	5
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	5
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences	5
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	5
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features	5